Literature DB >> 17203951

Histone H4 N-terminal acetylation in Kasumi-1 cells treated with depsipeptide determined by acetic acid-urea polyacrylamide gel electrophoresis, amino acid coded mass tagging, and mass spectrometry.

Liwen Zhang1, Xiaodan Su, Shujun Liu, Amy R Knapp, Mark R Parthun, Guido Marcucci, Michael A Freitas.   

Abstract

Disrupted patterns of acetylation and deacetylation of core histones play an important role in silencing transcription of hematopoietic important genes in acute myeloid leukemia (AML). A thorough investigation of these mechanisms and the response to pharmacologic modifiers will provide a better understanding of the role of histone acetylation in leukemogenesis. We describe here an analytical approach that combines acid urea polyacrylamide gel electrophoresis (AU-PAGE), amino acid coded mass tagging (AACM), and mass spectrometry (MS) for the investigation of histone acetylation patterns. The combined approach was used to follow the dynamics of H4 acetylation in Kasumi-1 cells harboring the fusion gene AML1/ETO shown to aberrantly recruit histone deacetylases (HDACs). The histones in Kasumi-1 cells were labeled by growing the cells in media in which lysine was replaced with stable isotope-labeled lysine (Lys-D4). Labeled and unlabeled cells were treated with depsipeptide and analyzed at different time points (0, 4, 8, 12, 24, and 48 h). The cells were mixed, the histone was extracted, and acetylated H4 isoforms were separated using AU-PAGE before in-gel trypsin digestion. The digests were analyzed by MALDI-TOF MS. Peptides were identified by mass and isotope pattern. LC-MS/MS of Arg-C digests were also performed to verify the acetylation pattern for H4. The major pattern of acetylation was determined as follows: initial acetylation at K16, followed by acetylation at K12, and finally acetylation of either K8 and/or K5.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17203951      PMCID: PMC2759876          DOI: 10.1021/pr060139u

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  62 in total

Review 1.  Histone deacetylases, transcriptional control, and cancer.

Authors:  W D Cress; E Seto
Journal:  J Cell Physiol       Date:  2000-07       Impact factor: 6.384

Review 2.  Role of histone acetylation in the assembly and modulation of chromatin structures.

Authors:  A T Annunziato; J C Hansen
Journal:  Gene Expr       Date:  2000

Review 3.  Mass spectrometric-based approaches in quantitative proteomics.

Authors:  Shao-En Ong; Leonard J Foster; Matthias Mann
Journal:  Methods       Date:  2003-02       Impact factor: 3.608

4.  Single peptide-based protein identification in human proteome through MALDI-TOF MS coupled with amino acids coded mass tagging.

Authors:  Songqin Pan; Sheng Gu; E Morton Bradbury; Xian Chen
Journal:  Anal Chem       Date:  2003-03-15       Impact factor: 6.986

5.  An integrated approach to identifying chemically induced posttranslational modifications using comparative MALDI-MS and targeted HPLC-ESI-MS/MS.

Authors:  Maria D Person; Terrence J Monks; Serrine S Lau
Journal:  Chem Res Toxicol       Date:  2003-05       Impact factor: 3.739

6.  Identification of novel histone post-translational modifications by peptide mass fingerprinting.

Authors:  Liwen Zhang; Ericka E Eugeni; Mark R Parthun; Michael A Freitas
Journal:  Chromosoma       Date:  2003-07-09       Impact factor: 4.316

Review 7.  Histone acetylation modifiers in the pathogenesis of malignant disease.

Authors:  U Mahlknecht; D Hoelzer
Journal:  Mol Med       Date:  2000-08       Impact factor: 6.354

8.  Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC).

Authors:  Shao-En Ong; Irina Kratchmarova; Matthias Mann
Journal:  J Proteome Res       Date:  2003 Mar-Apr       Impact factor: 4.466

9.  Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells.

Authors:  M I Klisovic; E A Maghraby; M R Parthun; M Guimond; A R Sklenar; S P Whitman; K K Chan; T Murphy; J Anon; K J Archer; L J Rush; C Plass; M R Grever; J C Byrd; G Marcucci
Journal:  Leukemia       Date:  2003-02       Impact factor: 11.528

Review 10.  Histone deacetylase inhibitors: from chromatin remodeling to experimental cancer therapeutics.

Authors:  Janine Arts; Stefanie de Schepper; Kristof Van Emelen
Journal:  Curr Med Chem       Date:  2003-11       Impact factor: 4.530

View more
  9 in total

Review 1.  Mass spectrometry-based strategies for characterization of histones and their post-translational modifications.

Authors:  Xiaodan Su; Chen Ren; Michael A Freitas
Journal:  Expert Rev Proteomics       Date:  2007-04       Impact factor: 3.940

2.  Early butyrate induced acetylation of histone H4 is proteoform specific and linked to methylation state.

Authors:  Tao Wang; Matthew V Holt; Nicolas L Young
Journal:  Epigenetics       Date:  2018-08-07       Impact factor: 4.528

3.  Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate.

Authors:  Shu-hao Hsu; Tasneem Motiwala; Satavisha Roy; Rainer Claus; Mufaddal Mustafa; Christoph Plass; Michael A Freitas; Kalpana Ghoshal; Samson T Jacob
Journal:  J Cell Biochem       Date:  2013-08       Impact factor: 4.429

4.  Computational micromodel for epigenetic mechanisms.

Authors:  Karthika Raghavan; Heather J Ruskin; Dimitri Perrin; Francois Goasmat; John Burns
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

5.  Unambiguous determination of isobaric histone modifications by reversed-phase retention time and high-mass accuracy.

Authors:  Lanhao Yang; Shengjiang Tu; Chen Ren; Esther M M Bulloch; Chung-Lin Liao; Ming-Daw Tsai; Michael A Freitas
Journal:  Anal Biochem       Date:  2009-08-21       Impact factor: 3.365

6.  Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression.

Authors:  Junko Suzuki; Yunn-Yi Chen; Gary K Scott; Sandy Devries; Koei Chin; Christopher C Benz; Frederic M Waldman; E Shelley Hwang
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

7.  Identification and verification of lysine propionylation and butyrylation in yeast core histones using PTMap software.

Authors:  Kai Zhang; Yue Chen; Zhihong Zhang; Yingming Zhao
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

8.  Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemia.

Authors:  Xiaodan Su; David M Lucas; Liwen Zhang; Hua Xu; Vlad Zabrouskov; Melanie E Davis; Amy R Knapp; Donn C Young; Philip R O Payne; Mark R Parthun; Guido Marcucci; Michael R Grever; John C Byrd; Michael A Freitas
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

9.  Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells.

Authors:  Valentina Barbetti; Antonella Gozzini; Giulia Cheloni; Ilaria Marzi; Emiliano Fabiani; Valeria Santini; Persio Dello Sbarba; Elisabetta Rovida
Journal:  Epigenetics       Date:  2013-01-15       Impact factor: 4.528

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.